FineMark National Bank & Trust’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

FineMark National Bank & Trust’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-800	Closed	-$10K	–	1242
2016 Q4	$10K	Hold	800	–	–	﹤0.01%	967
2016 Q3	$11K	Buy	+800	New	+$8.03K	﹤0.01%	932
2013 Q4	–	Sell	-47	Closed	-$1K	–	1624
2013 Q3	$1K	Buy	+47	New	+$913	﹤0.01%	1405

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return

FineMark National Bank & Trust's ARIA Position: Q1 2017 in Review

FineMark National Bank & Trust sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 800 shares — an estimated $10K sold.

FineMark National Bank & Trust first reported a position in ARIA in Q3 2013 and held it in 3 quarters. The position peaked at $11K in Q3 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

FineMark National Bank & Trust reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
FineMark National Bank & Trust sold 800 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $10K.
FineMark National Bank & Trust first reported a position in Ariad Pharmaceuticals Inc in Q3 2013 and held it in 3 quarters.
FineMark National Bank & Trust's Ariad Pharmaceuticals Inc position peaked at $11K in Q3 2016.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on FineMark National Bank & Trust's 13F filing for Q1 2017, filed 12 May 2017.